Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CLPBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 7.193B
December 31, 2025 7.673B
September 30, 2025 7.613B
June 30, 2025 7.533B
March 31, 2025 7.117B
December 31, 2024 6.712B
September 30, 2024 7.197B
June 30, 2024 6.982B
March 31, 2024 6.970B
December 31, 2023 7.200B
September 30, 2023 6.838B
June 30, 2023 5.506B
March 31, 2023 5.512B
December 31, 2022 5.412B
September 30, 2022 4.934B
June 30, 2022 4.946B
March 31, 2022 5.261B
December 31, 2021 2.475B
September 30, 2021 2.469B
June 30, 2021 2.465B
March 31, 2021 2.410B
December 31, 2020 2.454B
September 30, 2020 2.127B
June 30, 2020 2.006B
March 31, 2020 1.989B
Date Value
December 31, 2019 1.986B
September 30, 2019 1.859B
June 30, 2019 1.915B
March 31, 2019 1.849B
December 31, 2018 1.856B
September 30, 2018 1.833B
June 30, 2018 1.985B
March 31, 2018 2.104B
December 31, 2017 1.966B
September 30, 2017 1.914B
June 30, 2017 1.879B
March 31, 2017 1.799B
December 31, 2016 1.827B
September 30, 2016 1.661B
June 30, 2016 1.684B
March 31, 2016 1.622B
December 31, 2015 1.574B
September 30, 2015 1.619B
June 30, 2015 1.485B
March 31, 2015 1.527B
December 31, 2014 1.570B
September 30, 2014 1.761B
June 30, 2014 1.675B
March 31, 2014 1.713B
December 31, 2013 1.552B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Ambu A/S 1.173B
Abbott Laboratories 110.43B
AngioDynamics, Inc. 260.68M
Alphatec Holdings, Inc. 799.48M
AtriCure, Inc. 643.99M

Total Assets (Quarterly) Related Metrics